Sionna Therapeutics, Inc.
SION
$17.35
$1.519.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 269.67M | 147.54M | 38.52M | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4.01M | 3.46M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 273.68M | 150.99M | -- | ||
|
|
|||||
| Total Current Assets | 273.68M | 150.99M | -- | ||
| Net Property, Plant & Equipment | 10.01M | 10.30M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 962.00K | 3.96M | -- | ||
| Total Assets | 369.67M | 185.75M | -- | ||
|
|
|||||
| Total Accounts Payable | 5.02M | 1.19M | -- | ||
| Total Accrued Expenses | 3.35M | 7.67M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.12M | 1.07M | -- | ||
| Total Finance Division Other Current Liabilities | 39.00K | 492.00K | -- | ||
| Total Other Current Liabilities | 39.00K | 492.00K | -- | ||
| Total Current Liabilities | 9.53M | 10.42M | -- | ||
|
|
|||||
| Total Current Liabilities | 9.53M | 10.42M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 8.38M | 8.68M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 17.91M | 19.10M | -- | ||
|
|
|||||
| Common Stock & APIC | 549.04M | 17.01M | -- | ||
| Retained Earnings | -197.57M | -181.09M | -- | ||
| Treasury Stock & Other | 301.00K | 368.00K | -- | ||
| Total Common Equity | 351.77M | -163.71M | -114.88M | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 330.37M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 330.37M | 149.04M | ||
|
|
|||||
| Total Common Equity | 351.77M | -163.71M | -114.88M | ||
| Total Preferred Equity | -- | 330.37M | 149.04M | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 351.77M | 166.66M | 34.16M | ||
|
|
|||||